|
Market Closed -
Nasdaq
23:00:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 57.06 USD | +1.01% |
|
+30.30% | +85.26% |
| 10-30 | AlphaValue/Baader Europe Upgrades Genmab to Reduce | MT |
| 10-29 | Deutsche Bank raises price target for Genmab to DKK 4,000 (3,500), reiterates buy - BN | FW |
Company Valuation: Genmab A/S
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 172,063 | 192,229 | 140,770 | 94,810 | 124,862 | 233,758 | - | - |
| Change | - | 11.72% | -26.77% | -32.65% | 31.7% | 87.21% | - | - |
| Enterprise Value (EV) 1 | 152,725 | 169,905 | 112,635 | 73,709 | 114,029 | 253,607 | 245,655 | 231,999 |
| Change | - | 11.25% | -33.71% | -34.56% | 54.7% | 122.41% | -3.14% | -5.56% |
| P/E | 57.8x | 35.2x | 32.6x | 12.3x | 20.9x | 47.3x | 32.7x | 20.5x |
| PBR | 7.82x | 7.07x | 4.5x | 2.68x | 3.47x | 5.6x | 4.76x | 3.87x |
| PEG | - | 0.4x | -1.5x | 0.1x | -1x | -3.2x | 0.7x | 0.3x |
| Capitalization / Revenue | 20.3x | 13.2x | 8.54x | 4.4x | 5.31x | 7.75x | 6.44x | 4.97x |
| EV / Revenue | 18x | 11.6x | 6.84x | 3.42x | 4.85x | 8.41x | 6.77x | 4.93x |
| EV / EBITDA | 46.8x | 25.3x | 20.1x | 10.4x | 15.9x | 28.2x | 19.5x | 12.6x |
| EV / EBIT | 50.6x | 26.7x | 21.2x | 10.5x | 17x | 31.2x | 22.6x | 14.6x |
| EV / FCF | 77.3x | 47.3x | 16.1x | 9.72x | 15.7x | 41.5x | 31x | 17.3x |
| FCF Yield | 1.29% | 2.12% | 6.23% | 10.3% | 6.36% | 2.41% | 3.22% | 5.77% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 45.54 | 83.65 | 66.02 | 121.4 | 97.08 | 82.65 | 119.5 | 190.9 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 8,482 | 14,595 | 16,474 | 21,526 | 23,497 | 30,148 | 36,287 | 47,047 |
| EBITDA 1 | 3,266 | 6,719 | 5,616 | 7,116 | 7,175 | 9,001 | 12,624 | 18,451 |
| EBIT 1 | 3,018 | 6,357 | 5,321 | 7,003 | 6,727 | 8,133 | 10,859 | 15,905 |
| Net income 1 | 3,008 | 5,522 | 4,352 | 7,844 | 6,083 | 5,138 | 7,600 | 12,152 |
| Net Debt 1 | -19,338 | -22,324 | -28,135 | -21,101 | -10,833 | 19,848 | 11,897 | -1,759 |
| Reference price 2 | 2,630.00 | 2,941.00 | 2,155.00 | 1,492.50 | 2,027.00 | 3,912.00 | 3,912.00 | 3,912.00 |
| Nbr of stocks (in thousands) | 65,423 | 65,362 | 65,322 | 63,524 | 61,599 | 59,754 | - | - |
| Announcement Date | 2/16/22 A | 2/22/23 A | 2/14/24 A | 2/12/25 A | 2/17/26 A | - | - | - |
1DKK in Million2DKK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | |
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | |
| 37.48x | 6.65x | 19.85x | 0.86% | 54.62B | |
| 34.93x | 3.32x | 14.34x | -.--% | 44.06B | |
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | |
| -19.86x | 192.36x | -21.16x | -.--% | 41B | |
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | |
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | |
| -64.56x | 13.05x | -73.23x | -.--% | 24.7B | |
| Average | 18.13x | 28.02x | 6.57x | 0.34% | 43.82B | |
| Weighted average by Cap. | 22.09x | 26.34x | 10.94x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Valuation Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
